Carmine Bryce D.
EVP and Pres, Lilly Bio-Meds at LLY
- Sold, on record
- $2.7M
- Dollars the filings state
- Form 4 sales
- 16
- Latest Dec 12, 2011
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LLYELI LILLY & CoEVP and Pres, Lilly Bio-Meds
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LLYPlan not statedMay 11, 2011 2011
Sold 5,700 shares at $38.21 ($218k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 5.8% of holdings ($3.7M position)92,007 shares left1.8x usual sizeFiling
- 2 Form 4 sale LLYPlan not statedJun 13, 2011 +33 days
Sold 5,700 shares at $37.25 ($212k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 6.2% of holdings ($3.4M position)86,307 shares left1.8x usual sizeFiling
- 3 Form 4 sale LLYPlan not statedJul 11, 2011 +28 days
Sold 5,700 shares at $37.39 ($213k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 6.7% of holdings ($3.2M position)79,998 shares left1.8x usual sizeFiling
- 4 Form 4 sale LLYPlan not statedAug 11, 2011 +31 days
Sold 5,700 shares at $33.94 ($193k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 7.1% of holdings ($2.7M position)74,298 shares left1.8x usual sizeFiling
- 5 Form 4 sale LLYPlan not statedSep 12, 2011 +32 days
Sold 5,700 shares at $35.91 ($205k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 7.7% of holdings ($2.7M position)68,453 shares left1.8x usual sizeFiling
- 6 Form 4 sale LLYPlan not statedOct 11, 2011 +29 days
Sold 5,700 shares at $38.10 ($217k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 8.3% of holdings ($2.6M position)62,753 shares left1.8x usual sizeFiling
- 7 Form 4 sale LLYPlan not statedNov 11, 2011 +31 days
Sold 5,700 shares at $37.55 ($214k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 9.1% of holdings ($2.4M position)57,053 shares left1.3x usual sizeFiling
- 8 Form 4 sale LLYPlan not statedDec 12, 2011 +31 days
Sold 5,787 shares at $39.10 ($226k)
Carmine Bryce D., EVP and Pres, Lilly Bio-Meds
Sold 10.1% of holdings ($2.2M position)51,266 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2011 | Dec 14, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,787 | $226k | 10.1% | Plan not stated | SEC |
| Nov 11, 2011 | Nov 14, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $214k | 9.1% | Plan not stated | SEC |
| Oct 11, 2011 | Oct 13, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $217k | 8.3% | Plan not stated | SEC |
| Sep 12, 2011 | Sep 14, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $205k | 7.7% | Plan not stated | SEC |
| Aug 11, 2011 | Aug 12, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $193k | 7.1% | Plan not stated | SEC |
| Jul 11, 2011 | Jul 13, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $213k | 6.7% | Plan not stated | SEC |
| Jun 13, 2011 | Jun 15, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $212k | 6.2% | Plan not stated | SEC |
| May 11, 2011 | May 13, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $218k | 5.8% | Plan not stated | SEC |
| Apr 11, 2011 | Apr 12, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 5,700 | $204k | 5.5% | Plan not stated | SEC |
| Feb 16, 2011 | Feb 17, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $107k | 2.9% | Plan not stated | SEC |
| Jan 14, 2011 | Jan 18, 2011 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $108k | 5.2% | Plan not stated | SEC |
| Dec 16, 2010 | Dec 17, 2010 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $109k | 4.9% | Plan not stated | SEC |
| Nov 16, 2010 | Nov 17, 2010 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $107k | 4.7% | Plan not stated | SEC |
| Oct 15, 2010 | Oct 19, 2010 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $117k | 4.5% | Plan not stated | SEC |
| Sep 16, 2010 | Sep 17, 2010 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $110k | 4.3% | Plan not stated | SEC |
| Aug 16, 2010 | Aug 18, 2010 | LLY | EVP and Pres, Lilly Bio-Meds | Form 4 sale | 3,100 | $110k | 4.1% | Plan not stated | SEC |